GREY:IMVIF - Post by User
Comment by
QM45on Jan 02, 2021 12:24pm
327 Views
Post# 32209473
RE:Happy New Year!
RE:Happy New Year!Happy New Years to All!
The "update" if you can call it that was useless Alpha. I am trying to think of something you could hang your hat on and can't think of it.
Basically a gratuitous statement to pretend they actually "delivered" something. The whole program stinks of a cash grab from investors in a most blatant way.
Still, as inept as Ors and Co have been at progressing, they will stumble into some type of registration trial sooner rather than later given all the good data the programs have delivered.
IMV could have been sitting right up there with Moderna at $50-$100/ share based on their safe and easy to manufature technology and arguably were in excellent position to stay ahead with a completed RSV trial. But that would have required a competent and nimble team. Ors and Co are no such super stars. They have fumbled from Incyte days, still I do expect at some stage they will trip over a finish line.
So no worries here, at current valuations it's a joke and investing here is like shooting a fish in a barrell. They horded enough cash to execute, but are valued at $150M, a price of Toronto house these days...
So no brainer, sit back and wait for the 1920 locomotive to arrive...